Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Fibrinolytic Agents"" wg kryterium: Temat


Tytuł :
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.
Autorzy :
Sasanejad P; Department of Neurology Mashhad Fellowship of interventional radiology Mashhad University of Medical Sciences. Electronic address: .
Afshar Hezarkhani L; Department of Neurology School of Medicine Farabi Hospital Kermanshah University of Medical Sciences, Kermanshah, Iran.
Arsang-Jang S; Department of Biostatistics and Epidemiology School of Medicine Zanjan University of Medical Sciences, Zanjan, Iran.
Tsivgoulis G; Second Department of Neurology National & Kapodistrian University of Athens,Professor of Neurology, Athens, Greece.
Ghoreishi A; Department of Neurology, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences.
Kristian B; University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden.
Rahmig J; Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Farhoudi M; Neurosciences Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Sadeghi Hokmabadi E; Neurosciences Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz.
Borhani-Haghighi A; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sariaslani P; Department of Neurology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Sharifi-Razavi A; Clinical Research Development Unit of Bou-Ali Sina Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Ghandehari K; Department of Neurology Mashhad University of Medical Sciences, Mashhad, Iran.
Khosravi A; Clinical Immunology Research Center, Department of Neurology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Smith C; Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK; Division of Cardiovascular Sciences, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Nilanont Y; Siriraj Stroke Center, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Akbari Y; Departments of Neurology, Neurological Surgery, and Anatomy & Neurobiology, and Beckman Laser Institute & Medical Clinic, School of Medicine, University of California, Irvine, CA, USA.
Nguyen TN; Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
Bersano A; Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico carlo Besta, Milano, Italy.
Yassi N; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, Australia; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Yoshimoto T; Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Japan.
Lattanzi S; Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca, Ancona, Italy.
Gupta A; Department of Neurology, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
Zand R; Department of Neurology, Neuroscience Institute, Geisinger Medical Center, Danville, PA, USA.
Rafie S; Department of Neurology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Pourandokht Mousavian S; Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza Shahsavaripour M; Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran.
Amini S; Department of Anesthesia, Intensive care Unit, Lung Research Center, Mashhad, Mashhad University of Medical Sciences.
Kamenova SU; Department of Medicine, Al-Farabi Kazakh National University, Doctor of Medical Science, Professor. Almaty, Kazakhstan.
Kondybayeva A; Doctor of Medical Science, Professor Doctor of Medical Science, Professor, Department of Medicine, Al-Farabi Kazakh National University. Almaty, Kazakhstan.
Zhanuzakov M; Doctor of Medical Science Professor, Department of Internal Medicine, Kazakh-Russian Medical University. Almaty, Kazakhstan.
Macri EM; Department of Neurology, University of New Mexico, Albuquerque, NM.
Nobleza COS; Department of Neurology, University of Mississippi Medical Center, Jackson, MS.
Ruland S; Department of Neurology, Loyola University Chicago-Stritch School of Medicine, Chicago, IL.
Cervantes-Arslanian AM; Departments of Neurology, Neurosurgery, and Medicine (Infectious Disease), Boston University School of Medicine, Boston Medical Center, Boston, MA.
Desai MJ; Assistant Professor of Neurology, University of New Mexico, Albuquerque.
Ranta A; Department of Medicine, University of Otago, Wellington and Department of Neurology, Wellington Regional Hospital, New Zealand.
Moghadam Ahmadi A; Associate Professor of Neurology, School of Medicine, Non-communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Rostamihosseinkhani M; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Foroughi R; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Hooshmandi E; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Akhoundi FH; Department of Neurology, Iran University of medical Sciences, Tehran, Iran.
Shuaib A; Professor of Neurology and Director Stroke Program University of Alberta, Alberta, Canada.
Liebeskind DS; UCLA Stroke Center, Los Angeles, CA, USA.
Siegler J; Cooper Neurological Institute, Cooper University Hospital, Camden, NJ.
Romano JG; Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Mayer SA; Professor of Neurology and Neurosurgery, New York Medical College, Westchester Medical Center, Valhalla, NY.
Bavarsad Shahripour R; University of California San Diego Neurosciences center, Comprehensive Stroke center, San Diego, CA.
Zamani B; Department of Neurology, Iran University of Medical Sciences, Tehran, Iran.
Woolsey A; Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, Ontario, Canada. Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada.
Fazli Y; School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mojtaba K; Assistant Professor of Neurology, Assistant Professor of Neurology, Hamadan Medical University of Medical Sciences, Fellowship of neurovascular intervention.
Isaac CF; Department of Neurology, Hospital Dr Arturo Oñativia, Argentina.
Biller J; Department of Neurology, Loyola University Health System, Stritch School of Medicine, Chicago, IL, USA.
Di Napoli M; Department of Neurology and Stroke Unit, San Camillo de' Lellis General District Hospital, Rieti, Italy; Neurological Section, Neuro-epidemiology Unit, SMDN-Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention, Sulmona, L'Aquila, Italy.
Azarpazhooh MR; Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, Ontario, Canada; Department of Clinical Neurological Sciences, Western University, London, ON, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Dec; Vol. 30 (12), pp. 106121. Date of Electronic Publication: 2021 Sep 20.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Thrombolytic Therapy*/adverse effects
Thrombolytic Therapy*/mortality
COVID-19/*complications
Fibrinolytic Agents/*administration & dosage
Ischemic Stroke/*drug therapy
Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/mortality ; Disability Evaluation ; Europe ; Female ; Fibrinolytic Agents/adverse effects ; Hospital Mortality ; Humans ; Infusions, Intravenous ; Intracranial Hemorrhages/chemically induced ; Iran ; Ischemic Stroke/complications ; Ischemic Stroke/diagnosis ; Ischemic Stroke/mortality ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials.
Autorzy :
Talasaz AH; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.
Sadeghipour P; Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Aghakouchakzadeh M; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Kakavand H; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Ariannejad H; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Connors JM; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hunt BJ; Haemostasis and Thrombosis Centre, St Thomas' Hospital, London, UK.
Berger JS; Leon H. Charney Division of Cardiology, Department of Medicine, Center for the Prevention of Cardiovascular Disease, New York University School of Medicine, New York, New York, USA.
Van Tassell BW; Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.; Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.
Middeldorp S; Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.
Piazza G; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Weitz JI; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
Cushman M; Department of Medicine, University of Vermont Larner College of Medicine and University of Vermont Medical Center, Burlington, Vermont, USA.; Department of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine and University of Vermont Medical Center, Burlington, Vermont, USA.
Lip GYH; Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, UK.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Goldhaber SZ; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Bikdeli B; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.; Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Dec; Vol. 19 (12), pp. 3080-3089. Date of Electronic Publication: 2021 Sep 30.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
COVID-19*
Fibrinolytic Agents*/adverse effects
Antiviral Agents ; Humans ; Randomized Controlled Trials as Topic ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Antithrombotic Therapy for Outpatients With COVID-19: Implications for Clinical Practice and Future Research.
Autorzy :
Berwanger O; Academic Research Organization (ARO), Hospital Israelita Albert Einstein, São Paulo-SP, Brazil.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Nov 02; Vol. 326 (17), pp. 1685-1686.
Typ publikacji :
Editorial; Comment
MeSH Terms :
COVID-19*
Fibrinolytic Agents*/therapeutic use
Anticoagulants ; Humans ; Outpatients ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Impact of preoperative antithrombotic therapy in patients undergoing elective isolated coronary artery bypass grafting.
Autorzy :
van Steenbergen GJ; Cardiothoracic surgery department, Catharina Heart Centre, Catharina Hospital, ZA Eindhoven, Netherlands.
van Straten AHM; Cardiothoracic surgery department, Catharina Heart Centre, Catharina Hospital, ZA Eindhoven, Netherlands.
Kabak S; Cardiothoracic surgery department, Catharina Heart Centre, Catharina Hospital, ZA Eindhoven, Netherlands.
van Veghel D; Cardiothoracic surgery department, Catharina Heart Centre, Catharina Hospital, ZA Eindhoven, Netherlands.
Dekker L; Cardiothoracic surgery department, Catharina Heart Centre, Catharina Hospital, ZA Eindhoven, Netherlands.; Department of Biomedical Technology, Eindhoven University of Technology, Eindhoven, Netherlands.
Soliman-Hamad MA; Cardiothoracic surgery department, Catharina Heart Centre, Catharina Hospital, ZA Eindhoven, Netherlands.
Pokaż więcej
Źródło :
Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2021 Oct 29; Vol. 33 (5), pp. 702-709.
Typ publikacji :
Journal Article
MeSH Terms :
Fibrinolytic Agents*/adverse effects
Platelet Aggregation Inhibitors*/adverse effects
Coronary Artery Bypass/adverse effects ; Humans ; Postoperative Hemorrhage/chemically induced ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Evolving Post-PCI Antithrombotic Therapies.
Autorzy :
Ohman EM; From the Division of Cardiology, Duke Clinical Research Institute, Duke University, Durham, NC.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Oct 28; Vol. 385 (18), pp. 1712-1714. Date of Electronic Publication: 2021 Aug 28.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Fibrinolytic Agents*/adverse effects
Percutaneous Coronary Intervention*
Anticoagulants/adverse effects ; Humans ; Platelet Aggregation Inhibitors
Opinia redakcyjna
Tytuł :
Temporal Analysis of Tachycardia During Catheter Directed Thrombolysis for Acute Pulmonary Embolism.
Autorzy :
Graif A; Department of Vascular and Interventional Radiology, Christiana Care, Newark, DE, USA.
Grilli CJ; Department of Vascular and Interventional Radiology, Christiana Care, Newark, DE, USA.
Scott AL; Department of Radiology, Einstein Medical Center Montgomery, East Norriton, PA, USA.
Patel KD; Department of Vascular and Interventional Radiology, Christiana Care, Newark, DE, USA.
Zimmermann TJ; Department of Vascular and Interventional Radiology, Christiana Care, Newark, DE, USA.
Wimmer NJ; Department of Cardiology, Christiana Care, Newark, DE, USA.
Kimbiris G; Department of Vascular and Interventional Radiology, Christiana Care, Newark, DE, USA.
Leung DA; Department of Vascular and Interventional Radiology, Christiana Care, Newark, DE, USA.
Pokaż więcej
Źródło :
Vascular and endovascular surgery [Vasc Endovascular Surg] 2021 Oct; Vol. 55 (7), pp. 689-695. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
Heart Rate*
Thrombolytic Therapy*/adverse effects
Fibrinolytic Agents/*administration & dosage
Pulmonary Embolism/*drug therapy
Tachycardia, Sinus/*physiopathology
Tissue Plasminogen Activator/*administration & dosage
Adult ; Aged ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Male ; Middle Aged ; Pulmonary Embolism/complications ; Pulmonary Embolism/diagnosis ; Retrospective Studies ; Tachycardia, Sinus/diagnosis ; Tachycardia, Sinus/etiology ; Time Factors ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Risk of complications due to antithrombotic agents in cutaneous surgery: a systematic review and meta-analysis.
Autorzy :
Scherer FD; Division of Evidence-Based Medicine, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Dressler C; Division of Evidence-Based Medicine, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Valles GA; Division of Evidence-Based Medicine, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Nast A; Division of Evidence-Based Medicine, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Pokaż więcej
Źródło :
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2021 Oct; Vol. 19 (10), pp. 1421-1432. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Anticoagulants*/adverse effects
Fibrinolytic Agents*/adverse effects
Dermatologic Surgical Procedures ; Heparin/adverse effects ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł :
Auditing the scope of antithrombotic care in iPACT (International Pharmacists for Anticoagulation Care Taskforce) represented countries.
Autorzy :
Alves da Costa F; Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal. Electronic address: .
Rigby D; School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia.
Griffiths D; Westview Pharmacy, 5 Glendale Road, Auckland, 0602, New Zealand.
Antoniou S; St Bartholomew's Hospital, Cardiovascular Medicine, Barts Health NHS Trust, UCL Partners, UK.
Pokaż więcej
Źródło :
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2021 Oct; Vol. 17 (10), pp. 1764-1769. Date of Electronic Publication: 2021 Jan 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Fibrinolytic Agents*
Pharmacists*
Anticoagulants ; Health Services ; Humans
Czasopismo naukowe
Tytuł :
Anti-inflammatory and Anti-thrombotic Efficacy of Targeted Ultrasound Microbubbles on LPS-induced HUVEC Cells.
Autorzy :
Sun J; First People's Hospital of Linping District, Hangzhou, P.R. China.
Pan S; Hangzhou Normal University, Hangzhou, P.R. China.
Yu H; First People's Hospital of Linping District, Hangzhou, P.R. China.
Hu H; First People's Hospital of Linping District, Hangzhou, P.R. China.
Sun YU; Department of Surgery, UCSD, San Diego, CA, U.S.A.
Yang Z; AntiCancer Inc., San Diego, CA, U.S.A.
Hoffman RM; AntiCancer Inc., San Diego, CA, U.S.A.
Yuan H; First People's Hospital of Linping District, Hangzhou, P.R. China; .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 4761-4769.
Typ publikacji :
Journal Article
MeSH Terms :
Microbubbles*
Anti-Inflammatory Agents/*pharmacology
Fibrinolytic Agents/*pharmacology
Human Umbilical Vein Endothelial Cells/*drug effects
Anti-Inflammatory Agents/chemistry ; Atherosclerosis/chemically induced ; Atherosclerosis/metabolism ; Atherosclerosis/therapy ; Cell Adhesion ; Endostatins/chemistry ; Endostatins/pharmacology ; Fibrinolytic Agents/chemistry ; Human Umbilical Vein Endothelial Cells/metabolism ; Humans ; Inflammation Mediators/metabolism ; Intercellular Adhesion Molecule-1/immunology ; Intercellular Adhesion Molecule-1/metabolism ; Lipopolysaccharides/toxicity ; Recombinant Proteins/chemistry ; Recombinant Proteins/pharmacology ; Ultrasonics
Czasopismo naukowe
Tytuł :
Network Meta-analysis of the Benefit of Aspirin with Rivaroxaban vs. Clopidogrel for Patients with Stable Symptomatic Lower Extremity Arterial Disease.
Autorzy :
Ambler GK; Bristol Centre for Surgical Research, Bristol Medical School, University of Bristol, UK.
Nordanstig J; Department of Vascular Surgery and Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital and Academy, Gothenburg University, Sweden.
Behrendt CA; Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Germany.
Twine CP; Bristol Centre for Surgical Research, Bristol Medical School, University of Bristol, UK. Electronic address: .
Pokaż więcej
Źródło :
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery [Eur J Vasc Endovasc Surg] 2021 Oct; Vol. 62 (4), pp. 654-655. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji :
Letter; Meta-Analysis
MeSH Terms :
Aspirin/*therapeutic use
Clopidogrel/*therapeutic use
Factor Xa Inhibitors/*therapeutic use
Fibrinolytic Agents/*therapeutic use
Lower Extremity/*blood supply
Peripheral Arterial Disease/*drug therapy
Platelet Aggregation Inhibitors/*therapeutic use
Rivaroxaban/*therapeutic use
Aged ; Aspirin/adverse effects ; Clopidogrel/adverse effects ; Factor Xa Inhibitors/adverse effects ; Female ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Network Meta-Analysis ; Peripheral Arterial Disease/diagnosis ; Peripheral Arterial Disease/physiopathology ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Rivaroxaban/adverse effects ; Treatment Outcome
Raport
Tytuł :
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
Autorzy :
Gusev EI; Department of Neurology, Pirogov Russian National Research Medical University of the Russian Ministry of Health, Moscow, Russia. Electronic address: .
Martynov MY; Department of Neurology, Pirogov Russian National Research Medical University of the Russian Ministry of Health, Moscow, Russia.
Nikonov AA; Department of Neurology, Pirogov Russian National Research Medical University of the Russian Ministry of Health, Moscow, Russia.
Shamalov NA; Federal State Budgetary Institution, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia.
Semenov MP; Medical Department, Peoples' Friendship University of Russia, Moscow, Russia.
Gerasimets EA; Medical Department, Peoples' Friendship University of Russia, Moscow, Russia.
Yarovaya EB; Faculty of Mechanics and Mathematics, Lomonosov Moscow State University, Moscow, Russia.
Semenov AM; Medical Department, Peoples' Friendship University of Russia, Moscow, Russia; SuperGene, Moscow, Russia.
Archakov AI; Institute of Biomedical Chemistry, Moscow, Russia.
Markin SS; Institute of Biomedical Chemistry, Moscow, Russia; SuperGene, Moscow, Russia.
Pokaż więcej
Corporate Authors :
FRIDA Study Group
Źródło :
The Lancet. Neurology [Lancet Neurol] 2021 Sep; Vol. 20 (9), pp. 721-728.
Typ publikacji :
Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Time-to-Treatment*
Fibrinolytic Agents/*pharmacology
Ischemic Stroke/*drug therapy
Metalloendopeptidases/*pharmacology
Tissue Plasminogen Activator/*pharmacology
Aged ; Aged, 80 and over ; Double-Blind Method ; Female ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/adverse effects ; Humans ; Male ; Metalloendopeptidases/administration & dosage ; Metalloendopeptidases/adverse effects ; Metalloendopeptidases/immunology ; Middle Aged ; Outcome Assessment, Health Care ; Recombinant Proteins ; Russia ; Tissue Plasminogen Activator/administration & dosage ; Tissue Plasminogen Activator/adverse effects
Czasopismo naukowe
Tytuł :
Bioevaluation of Pheretima vulgaris Antithrombotic Extract, PvQ , and Isolation, Identification of Six Novel PvQ -Derived Fibrinolytic Proteases.
Autorzy :
Yang W; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, China.
Wang W; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, China.
Ma Y; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, China.
Yang Q; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, China.
Li P; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, China.
Du S; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, China.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Aug 16; Vol. 26 (16). Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article
MeSH Terms :
Fibrinolytic Agents/*isolation & purification
Fibrinolytic Agents/*pharmacology
Oligochaeta/*chemistry
Peptide Hydrolases/*pharmacology
Thrombosis/*pathology
Amino Acid Sequence ; Animals ; Base Sequence ; Cell Survival/drug effects ; Databases, Protein ; Erythrocytes/drug effects ; Fibrinolysis/drug effects ; Fibrinolytic Agents/chemistry ; Human Umbilical Vein Endothelial Cells/cytology ; Human Umbilical Vein Endothelial Cells/drug effects ; Humans ; Models, Molecular ; Peptide Hydrolases/chemistry ; Peptide Hydrolases/genetics ; Protein Structure, Secondary ; Protein Structure, Tertiary ; Tissue Plasminogen Activator/metabolism ; Zebrafish
Czasopismo naukowe
Tytuł :
Reverse tracing anti-thrombotic active ingredients from dried Rehmannia Radix based on multidimensional spectrum-effect relationship analysis of steaming and drying for nine cycles.
Autorzy :
Gong PY; Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China; College of Pharmacy, Southwest Minzu University, Chengdu, 610041, China. Electronic address: .
Guo YJ; Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: .
Tian YS; Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: .
Gu LF; Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: .
Qi J; Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: .
Yu BY; Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of ethnopharmacology [J Ethnopharmacol] 2021 Aug 10; Vol. 276, pp. 114177. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article
MeSH Terms :
Drugs, Chinese Herbal/*chemistry
Drugs, Chinese Herbal/*pharmacology
Fibrinolytic Agents/*chemistry
Fibrinolytic Agents/*pharmacology
Rehmannia/*chemistry
Thrombosis/*drug therapy
Animals ; Chromatography, High Pressure Liquid ; Desiccation ; Disease Models, Animal ; Drug Synergism ; Drugs, Chinese Herbal/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Interleukin-1beta/blood ; Iridoid Glycosides/pharmacology ; Male ; Medicine, Chinese Traditional ; Mice, Inbred ICR ; Monosaccharides/analysis ; Multivariate Analysis ; Oligosaccharides/analysis ; Oligosaccharides/pharmacology ; Plasminogen Activator Inhibitor 1/blood ; Principal Component Analysis ; Secondary Metabolism ; Steam ; Thrombosis/chemically induced ; Tissue Plasminogen Activator/blood ; Tumor Necrosis Factor-alpha/blood
Czasopismo naukowe
Tytuł :
Tissue Plasminogen Activator Use in Pediatric Patients: A Single Center Experience.
Autorzy :
Pekpak E; Gaziantep University School of Medicine, Gaziantep.
İnce E; Ankara University School of Medicine, Ankara, Turkey.
Ertem M; Ankara University School of Medicine, Ankara, Turkey.
Tutar E; Ankara University School of Medicine, Ankara, Turkey.
İleri T; Ankara University School of Medicine, Ankara, Turkey.
Ucar T; Ankara University School of Medicine, Ankara, Turkey.
Tiras ST; Ankara University School of Medicine, Ankara, Turkey.
Cakmakli HF; Ankara University School of Medicine, Ankara, Turkey.
Uysal Z; Ankara University School of Medicine, Ankara, Turkey.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Jul 01; Vol. 43 (5), pp. e648-e651.
Typ publikacji :
Journal Article
MeSH Terms :
Fibrinolytic Agents/*therapeutic use
Thrombosis/*drug therapy
Tissue Plasminogen Activator/*therapeutic use
Child ; Child, Preschool ; Female ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Humans ; Infant ; Male ; Tissue Plasminogen Activator/administration & dosage ; Tissue Plasminogen Activator/adverse effects
Czasopismo naukowe
Tytuł :
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
Autorzy :
Kahale LA; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Matar CF; Department of Internal Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Tsolakian I; Department of Obstertrics and Gynaecology, University of Toledo College of Medicine and Life Sciences, Ohio, USA.
Hakoum MB; Department of Family Medicine, Cornerstone Care Teaching Health Center, Mount Morris, Pennsylvania, USA.
Yosuico VE; Buffalo Medical Group, Buffalo, New York, USA.
Terrenato I; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Sperati F; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Barba M; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Hicks LK; Medicine, St. Michael's Hospital and the University of Toronto, Toronto, Canada.
Schünemann H; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Akl EA; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Sep 28; Vol. 9. Cochrane AN: CD014739. Date of Electronic Publication: 2021 Sep 28.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Fibrinolytic Agents*
Multiple Myeloma*/drug therapy
Anticoagulants/adverse effects ; Heparin ; Heparin, Low-Molecular-Weight ; Humans ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł :
Antithrombotic therapy in the elderly: The more we know, the more we can offer.
Autorzy :
Lemos PA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Instituto do Coração (InCor), São Paulo Medical School, São Paulo, SP, Brazil. Electronic address: .
Guimarães PO; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Franken M; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Berwanger O; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2021 Sep 15; Vol. 339, pp. 58-59. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Fibrinolytic Agents*/adverse effects
Warfarin*
Aged ; Anticoagulants ; Humans
Opinia redakcyjna
Tytuł :
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.
Autorzy :
Shi H; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.; Division of Rheumatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gandhi AA; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Smith SA; Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
Wang Q; Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
Chiang D; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Yalavarthi S; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Ali RA; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Liu C; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Sule G; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Tsou PS; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Zuo Y; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kanthi Y; Division of Intramural Research National Heart, Lung and Blood Institute Bethesda, Maryland, USA.; Division of Cardiovascular Medicine, Department of Internal Medicine and.
Farkash EA; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Lin JD; Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
Morrissey JH; Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
Knight JS; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło :
JCI insight [JCI Insight] 2021 Sep 08; Vol. 6 (17). Date of Electronic Publication: 2021 Sep 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Fibrinolytic Agents/*pharmacology
Human Umbilical Vein Endothelial Cells/*drug effects
Polydeoxyribonucleotides/*pharmacology
Thrombosis/*drug therapy
Animals ; Extracellular Traps/drug effects ; Extracellular Traps/metabolism ; Fibrinolytic Agents/therapeutic use ; Histones/metabolism ; Human Umbilical Vein Endothelial Cells/metabolism ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Polydeoxyribonucleotides/therapeutic use ; Pyroptosis
Czasopismo naukowe
Tytuł :
Evaluation of thrombolytic treatment effect on frontal plane QRS-T angle in patients with acute pulmonary embolism : A novel marker of successful thrombolysis.
Autorzy :
Şahan E; Cardiology, Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Ankara, Turkey. .
Aydemir S; Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Anesthesia and Reanimation, Ankara, Turkey.
Pokaż więcej
Transliterated Title :
Untersuchung des Effekts der Thrombolysetherapie auf den QRS-T-Winkel in der Frontalebene bei Patienten mit akuter Lungenembolie : Neuer Marker erfolgreicher Thrombolyse.
Źródło :
Herz [Herz] 2021 Sep; Vol. 46 (Suppl 2), pp. 187-190.
Typ publikacji :
Journal Article
MeSH Terms :
Fibrinolytic Agents*/therapeutic use
Pulmonary Embolism*/diagnosis
Pulmonary Embolism*/drug therapy
Acute Disease ; Electrocardiography ; Humans ; Thrombolytic Therapy
Czasopismo naukowe
Tytuł :
Comments on: Impact of discontinuation of antithrombotic therapy after surgery for chronic subdural hematoma, Todeschi et al., Neurochirurgie 66 (4) (2020) 195-202.
Autorzy :
Lozada-Martínez ID; Medical-Surgical Research Center, University of Cartagena, Cartagena, Colombia.
Bolaño-Romero MP; Medical-Surgical Research Center, University of Cartagena, Cartagena, Colombia.
Moscote-Salazar LR; Neurosurgeon-Critical Care, Biomedical Research Center, University of Cartagena, Cartagena de Indias, Colombia. Electronic address: .
Torres-Llinas DM; Medical-Surgical Research Center, University of Cartagena, Cartagena, Colombia.
Pokaż więcej
Źródło :
Neuro-Chirurgie [Neurochirurgie] 2021 Sep; Vol. 67 (5), pp. 529-530. Date of Electronic Publication: 2020 Oct 29.
Typ publikacji :
Letter; Comment
MeSH Terms :
Fibrinolytic Agents*/therapeutic use
Hematoma, Subdural, Chronic*/drug therapy
Hematoma, Subdural, Chronic*/surgery
Anticoagulants ; Humans ; Trephining
Opinia redakcyjna
Tytuł :
[Management of bleeding in patients on antithrombotic therapy].
Autorzy :
Braun G; Intensivzentrum, Medizinische Klinik 3 am Universitätsklinikum Augsburg, Stenglinstr. 2, 86156, Augsburg, Deutschland. .
Pokaż więcej
Transliterated Title :
Management von Blutungen unter antithrombotischer Therapie.
Źródło :
Medizinische Klinik, Intensivmedizin und Notfallmedizin [Med Klin Intensivmed Notfmed] 2021 Sep; Vol. 116 (6), pp. 491-498. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Fibrinolytic Agents*/adverse effects
Hemorrhage*/drug therapy
Hemorrhage*/therapy
Administration, Oral ; Anticoagulants/adverse effects ; Antidotes/therapeutic use ; Factor Xa Inhibitors/adverse effects ; Humans ; Recombinant Proteins/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies